Showing results (91-100 of 130) with videos related to
Sort By:
Pageof 13
Communications Biology|January 12, 2022
The metabolic stress-activated checkpoint LKB1-MARK3 axis acts as a tumor suppressor in high-grade serous ovarian carcinomaHidenori Machino, Syuzo Kaneko, Masaaki Komatsu, et al.BMC Cancer|December 16, 2025
Synthetic lethality from the combination of a histone methyltransferase SUV39H2 inhibitor and a poly (ADP-ribose) polymerase inhibitor for uterine leiomyosarcomaYusuke Toyohara, Kenbun Sone, Kohei Kumegawa, et al.HLA|June 5, 2024
Allelic loss of HLA class I facilitates evasion from immune surveillance in cervical intraepithelial neoplasiaKatsushige Kawase, Ayumi Taguchi, Aya Ishizaka, et al.Journal of Perinatology : Official Journal of the California Perinatal Association|September 18, 2024
Neurological outcomes and associated perinatal factors in infants born between 22 and 25 weeks with active careYu Ariyoshi, Takayuki Iriyama, Takahiro Seyama, et al.Journal of Reproductive Immunology|October 6, 2022
Increased production of inflammatory cytokines and activation of microglia in the fetal brain of preeclamptic mice induced by angiotensin IIYoshihisa Katoh, Takayuki Iriyama, Eriko Yano, et al.Oncogene|February 24, 2025
Cyclin E1 overexpression sensitizes ovarian cancer cells to WEE1 and PLK1 inhibitionQian Xi, Akiko Kunita, Miho Ogawa, et al.Gynecologic Oncology|April 16, 2016
Significance of survivin as a prognostic factor and a therapeutic target in endometrial cancerAgapiti Hipoliti Chuwa, Kenbun Sone, Katsutoshi Oda, et al.Cancer Science|July 27, 2020
Effect of murine double-minute 2 inhibitors in preclinical models of advanced clear cell carcinomas originating from ovaries and kidneysYoshiko Kawata, Kazunori Nagasaka, Katsutoshi Oda, et al.Biochemical and Biophysical Research Communications|March 4, 2022
Histone arginine methyltransferase CARM1 selective inhibitor TP-064 induces apoptosis in endometrial cancerFutaba Inoue, Kenbun Sone, Yusuke Toyohara, et al.British Journal of Cancer|November 12, 2015
Prognostic importance of CDK4/6-specific activity as a predictive marker for recurrence in patients with endometrial cancer, with or without adjuvant chemotherapyYuji Ikeda, Katsutoshi Oda, Hideki Ishihara, et al.Pageof 13